14 coding-"https:" "https:" "https:" "https:" "https:" "https:" "University of California" "U.S" "U.S" uni jobs at Center for Biologics Evaluation and Research (CBER)

FDA Computational and Experimental Assessment of Engineered Biotherapeutics: Safety and Regulatory Considerations of Synonymous Gene Recoding

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 13 days ago

Biol, 169718 (2026). https://doi.org:10.1016/j.jmb.2026.169718 Katneni, U.K., Liss, A., Holcomb, D., Katagiri, N., Hunt, R.C., Bar, H., Ismail, A., Komar, A.A. and Kimchi-Sarfaty, C.: Splicing

FDA Research Opportunity - Developing Methods for Efficient Gene Editing in Hematopoietic Stem Cells (HSCs)

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 11 hours ago

Therapy and Human Tissue (OCTHT) at the Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA) located in Silver Spring, Maryland. The Center for Biologics Evaluation

FDA Research Opportunity - Bacteriophage Therapy

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 11 hours ago

of FDA and is contingent on the availability of funds. Level of Participation: The appointment is full time. Citizenship Requirements: This opportunity is available to U.S. citizens, Lawful Permanent

FDA Research Opportunity in Developing Methods for Efficient Gene Editing in Hematopoietic Stem Cells (HSCs)

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 13 days ago

Therapy and Human Tissue (OCTHT) at the Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA) located in Silver Spring, Maryland. The Center for Biologics Evaluation

FDA Research Opportunity - Immune Responses to Influenza Vaccines

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 12 days ago

: The appointment is full time. Citizenship Requirements: This opportunity is available to U.S. citizens, Lawful Permanent Residents (LPR), and foreign nationals. Non-U.S. citizen applicants should refer to

FDA Research Opportunity - Influenza Vaccine Assay Development

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 11 hours ago

available to U.S. citizens and, Lawful Permanent Residents (LPR). This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and

FDA Research Opportunity - Dengue Neutralization Assay

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 11 hours ago

Products (DVP), at the Center for Biologics Evaluation and Research (CBER), U.S. Food & Drug Administration (FDA) in Silver Spring, Maryland. This is for viral vaccine research for those who are interested

FDA Focus Towards More Efficient Factor VIII Drug Products to Improve the Treatment of Hemophilia A

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 9 days ago

Evaluation and Research (CBER), U.S. Food & Drug Administration (FDA) in Silver Spring, Maryland. Research Project: The project will focus on investigating the biochemical mechanisms of blood coagulation

FDA Evaluation of Platelets: Antimicrobial Treatments and Evaluation of the Treated Products for Functions

Center for Biologics Evaluation and Research (CBER) | Southern Md Facility, Maryland | United States | 13 days ago

, and cellular and gene therapies. The ORISE Research Participation Program at the U.S. Food and Drug Administration is an educational and training program designed to provide college students, recent

FDA Tick-Borne Pathogen Research Program

Center for Biologics Evaluation and Research (CBER) | Southern Md Facility, Maryland | United States | about 11 hours ago

the regulation of biological and related products including blood, vaccines, allergenics, tissues, and cellular and gene therapies. The ORISE Research Participation Program at the U.S. Food and Drug Administration